Mission
The Center for Gene Therapy at the University of Michigan Medical
Center was created to link basic science, clinical investigation and
technology transfer. The Center fosters a multidisciplinary approach
to new research as well as collaborative research endeavors in the
area of gene therapy; extends the services of existing and newly
created research cores to investigators; and serves as a resource
for information and education.
Scope
of Activities
To aid medical researchers, we have divided the Center into four
programs. Each program offers products and services to aid the
medical researcher here at Michigan and elsewhere. The
products and services are :
Background
The University of Michigan is an established leader in the field of
gene therapy and molecular medicine and has pioneered a number of
the most innovative gene therapy techniques to be tested in the
United States.
Although individual scientists at the University of Michigan have
been involved in the field of molecular genetics for many years, the
institutional commitment to gene therapy is an outgrowth of a
long-standing commitment to the field of human genetics. The
department of Human Genetics was formed at the University of
Michigan in 1941, initially as the Heredity Clinic under the
guidance of Dr. Lee R. Dice. Upon his retirement in 1956, professor
Dr. James V. Neel became the head of the new Department of Human
Genetics, which, along with the Heredity Clinic, is widely
recognized as the first of its kind in the nation. In 1983, a unit
of the Howard Hughes Medical Institute at the University of Michigan
Medical Center was established, whose stated mission was the
“clinical application of molecular genetics,” with gene transfer
identified as one of its formal goals. In succeeding years, the
Institute and the Medical Center have jointly recruited an
outstanding group of scientists in this field. The continuing work
of these investigators provides a solid base of scientific knowledge
and hands-on experience directly related to gene therapy.
|